The global vaso occlusive crisis associated with sickle cell disease drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The vaso-occlusive crisis associated with sickle cell disease is a common painful complication of sickle cell disease that occurs in adolescents and adults. The major factor driving the growth of the market is the rising prevalence of sickle cell disease across the globe.
According to the Center for Disease Control and Prevention (CDC), in 2020, SCD affects approximately 100,000 Americans and occurs about 1 out of every 365 Black or African-American births. Additionally, SCD occurs among about 1 out of every 16,300 Hispanic-American births and about 1 in 13 Black or African-American babies is born with sickle cell trait (SCT). Hence, the increasing prevalence of SDC is increasing the risk for vaso occlusive crisis associated with sickle cell disease which in turn is driving the growth of the market.
To Request a Sample of our Report on Vaso Occlusive Crisis Associated With Sickle Cell Disease Drug Market: https://www.omrglobal.com/request-sample/vaso-occlusive-crisis-associated-with-sickle-cell-disease-drug-market
Some major players in the market include AstraZeneca Plc, Bristol-Myers Squibb Co., and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2019, Novartis announced that it has received approval for Adakveo (crizanlizumab-tmca) from the US FDA. It is used for the treatment to reduce the frequency of vaso-occlusive crisis associated with sickle cell disease for patients age 16 years and older.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– AstraZeneca Plc, Bristol-Myers Squibb Co., and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Vaso Occlusive Crisis Associated With Sickle Cell Disease Drug Market is Available @ https://www.omrglobal.com/industry-reports/vaso-occlusive-crisis-associated-with-sickle-cell-disease-drug-market
Global Vaso Occlusive Crisis Associated with Sickle Cell Disease Drug Market Report by Segment
By Type
- SGD-2083
- Crizanlizumab
- PF-04447943
- NVX-508
- Others
By Application
- Hospital
- Clinic
- Other
Global Vaso Occlusive Crisis Associated with Sickle Cell Disease Drug Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
